We are live on
!
Find out more
LCG
Lisanti Capital Growth Portfolio holdings
AUM
$397M
1-Year Est. Return
178.66%
This Fund
S&P 500
This Quarter
Est. Return
+50.21%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$723M
AUM Growth
+$183M
(+34%)
Cap. Flow
+$2.46M
Cap. Flow
% of AUM
0.34%
Top 10 Holdings %
Top 10 Hldgs %
18.74%
Holding
158
New
48
Increased
40
Reduced
30
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coherent
COHR
|
+$9.57M |
| 2 |
Terex
TEX
|
+$7.87M |
| 3 |
PagerDuty
PD
|
+$7.71M |
| 4 |
Pulmonx
LUNG
|
+$7.67M |
| 5 |
Arrowhead Research
ARWR
|
+$6.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Builders FirstSource
BLDR
|
+$12.3M |
| 2 |
Tandem Diabetes Care
TNDM
|
+$11.4M |
| 3 |
Palomar
PLMR
|
+$11.2M |
| 4 |
Pacira BioSciences
PCRX
|
+$10.1M |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$9.84M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.34% |
| 2 | Technology | 27.5% |
| 3 | Industrials | 19.61% |
| 4 | Consumer Discretionary | 17.32% |
| 5 | Financials | 3.72% |
Similar funds
GF
PIM
EH
TPWA
ECA
DL
STT
VC
Lisanti Capital Growth's Q4 2020 Portfolio in Review
As of Q4 2020, Lisanti Capital Growth held 158 positions worth $723M, up 34% from $540M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Lisanti Capital Growth's Q4 2020 filing shows 48 new, 40 increased, 30 reduced and 31 closed positions. Its largest new stake was Coherent: 161,475 shares worth $12.3M. The largest sale was Builders FirstSource, an estimated $12.3M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.
- Lisanti Capital Growth's largest Q4 2020 buy was Coherent: 161,475 shares worth $12.3M.
- Lisanti Capital Growth added most to Boot Barn in Q4 2020, an estimated $6.35M increase.
- Lisanti Capital Growth's biggest Q4 2020 reduction was Builders FirstSource, cutting an estimated $12.3M.
- Lisanti Capital Growth fully exited Tandem Diabetes Care in Q4 2020, selling an estimated $11.4M.
- Lisanti Capital Growth's ten largest holdings make up 19% of its $723M portfolio in Q4 2020.
- Lisanti Capital Growth opened 48 new positions and closed 31 in Q4 2020.
- Lisanti Capital Growth's portfolio value rose 34% quarter-over-quarter to $723M.
Based on Lisanti Capital Growth's 13F filing for Q4 2020, filed 10 Feb 2021.